Quinsam Capital Corporation

Management did not disclose revenue, EPS, gross margin, or other quarter-specific financial statements on the call, saying investors had likely already seen the press release. The company said it “made some money” in Q2 and retired more shares, while cash is ready to deploy and the liquid portfolio is increasing. For Q3, management said the key event is Peninsula Capital’s expected listing, which they believe could move about $0.02 from the private portfolio to the public portfolio; they also expect Pelican AI, Longview Gold, and Bon Intelligence to list later and add positively to NAV. No formal financial guidance for revenue or earnings was provided.

Roger Dent’s tone was cautiously upbeat: he characterized Q2 as modestly positive and said the portfolio appears to be turning. He emphasized that the firm has a low cost base in several private holdings and sees value creation ahead as these names list and become more liquid. He also said the issuer bid reflects management’s view that the stock is undervalued, though execution has become harder under current CSE rules.

No separate CFO remarks were provided. Management said Quinsam has cash ready to deploy, that it has increased its proportion of assets in the liquid portfolio, and that it retired more shares during the quarter. Dent also pointed to Peninsula Capital as a major valuation event, saying the company is carried at $1.45 and is expected to come out with a dividend and an NAV around $2, while Bon Intelligence was described as a roughly $250,000 investment and Longview Gold and Pelican AI were said to be smaller positions.

The main analyst/shareholder questions focused on California Nanotech and the issuer bid. On California Nanotech, Dent said the company is optimistic about near-term commercial contracts in small nuclear reactors and believes it may be a key supplier of boron control rods and heat shielding, while also pursuing U.S. government funding; however, he stressed no contracts or funding have been secured yet. On the issuer bid, management said repurchases signal confidence in value, but they are hard to execute because of tougher rules and the stock’s illiquidity.